par Early Breast Cancer Trialists' Collaborative Group (EBCTCG), R;Peto, C;Davies, J;Godwin, Richard;Gray, Huade;Pan, M;Clarke, D;Cutter, S;Darby, P;McGale, C;Taylor, Yue;Wang, Jonas;Bergh, Angelo;Di Leo, Kathy S
;Albain, S;Swain, Martine;Piccart-Gebhart, Kathleen
;Pritchard,
Référence Lancet, 379, 9814, page (432-444)
Publication Publié, 2012-02


Référence Lancet, 379, 9814, page (432-444)
Publication Publié, 2012-02
Article révisé par les pairs
Titre: |
|
Auteur: | Early Breast Cancer Trialists' Collaborative Group (EBCTCG), R; Peto, C; Davies, J; Godwin, Richard; Gray, Huade; Pan, M; Clarke, D; Cutter, S; Darby, P; McGale, C; Taylor, Yue; Wang, Jonas; Bergh, Angelo; Di Leo, Kathy S; Albain, S; Swain, Martine; Piccart-Gebhart, Kathleen; Pritchard, |
Informations sur la publication: | Lancet, 379, 9814, page (432-444) |
Statut de publication: | Publié, 2012-02 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Anthracyclines -- administration & dosage |
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
Breast Neoplasms -- drug therapy -- mortality | |
Chemotherapy, Adjuvant | |
Female | |
Humans | |
Neoplasm Recurrence, Local | |
Randomized Controlled Trials as Topic | |
Survival Rate | |
Taxoids -- administration & dosage | |
Note générale: | Comparative Study |
Journal Article | |
Meta-Analysis | |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0140-6736 |
info:doi/10.1016/S0140-6736(11)61625-5 | |
info:pii/S0140-6736(11)61625-5 | |
info:pmid/22152853 | |
PMC3273723 |